Onego Bio
Seedtable Score
41
Startups
2
Funding Rounds
6
Investors
$26.56m
Money raised
Overview
Onego Bio, an animal-free egg protein producer based in Helsinki, shows strong potential in the biotech and food innovation sectors. By targeting food manufacturers through a B2B model, the company aims to disrupt traditional egg farming, which is fraught with ethical and environmental issues. Their sustainable, animal-free egg proteins cater to the growing market of vegans and environmentally conscious consumers, distinguishing them from companies dependent on conventional animal agriculture. Backed by investors like EIT Food and NordicNinja VC, Onego Bio has the financial support to scale its solutions and potentially capture significant market share as demand for sustainable food alternatives grows.
- Website: https://onego.bio
- Business model: b2b, b2c
- Company size: 11 - 51 employees
- Headquarters: Helsinki, Finland
- Founded: 2022
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (6)
Funding
Funding series
Funding Series Analysis
The company Onego Bio has raised a total of $26.56m in funding over 2 rounds.
Key Insights:
- Seed: $11.36m
- Series A: $15.2m
Onego Bio Seed (2022, $11M)
$11.36m
Onego Bio Series A (2024, $15M)
$15.2m